NCT07855549

Brief Summary

The aim of this study is to evaluate the effect of combined pectoralis II and serratus interfascial plane blocks in comparison with erector spinae plane block on post-operative analgesia after thoracic surgeries.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
1mo left

Started Apr 2025

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Apr 2025Nov 2026

Study Start

First participant enrolled

April 1, 2025

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

September 28, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 2, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Last Updated

October 2, 2026

Status Verified

November 1, 2025

Enrollment Period

1.6 years

First QC Date

September 28, 2026

Last Update Submit

September 28, 2026

Conditions

Keywords

Nerve block in thoracic surgery

Outcome Measures

Primary Outcomes (1)

  • First analgesic request

    The time of first request to analgesia by patient post operative

    24 hours

Study Arms (3)

Erector spinae group

ACTIVE COMPARATOR

Sonar guided interfacial plane block deep to erector spinae muscle that targets dorsal and central Rami of spinal nerves

Procedure: Erector spinae plane block

Combined pectoralis and serratus anterior group

ACTIVE COMPARATOR

Sonar guided interfacial plane blocks firstly pectoralis plane block that targets lateral and medial pectoral nerves then serratus anterior plane block that targets lateral branches of intercostal nerves

Procedure: Combined pectoralis and serratus anterior plane blocks

Controlled group

NO INTERVENTION

This group doesn't receive any nerve block

Interventions

Patients will be positioned in the lateral position, The thoracic vertebrae spinous process convenient to level of incision (T5-T7:the level which covers thoracic area) will be identified and the transducer will be placed approximately to 2-3 cm lateral to midline ,The needle tip will be advanced until it is located in the interfascial plane deep to the erector spinae muscle group and superior to the transverse process. Once in position, 30 ml bupivacaine 0.25% will be injected under ultrasound guidance. Correct needle-tip position will be confirmed by the presence of linear spread between the transverse process and the presence of linear spread between the transverse process and the erector spinae muscle group.

Also known as: ESPB
Erector spinae group

Serratus anterior plane block will be performed with the patient in the supine position , The probe will be placed in a sagittal position, the mid-axillary region of the thoracic cage. The needle will be advanced with an in-plane technique and 20 ml bupivacaine 0.25% will be injected . PECS block will be performed at the same position. The ultrasound probe will be placed obliquely over the lateral third of the clavicle. the needle will be advanced, in the same plane as the probe, from the medial to lateral direction ,10 ml 0.25% bupivacaine will be injected. Then the needle will be advanced to the fascial plane between the pectoralis minor and serratus anterior muscles, at which point an additional 10 ml 0.25% bupivacaine will be administered.

Also known as: PECS &SAPB
Combined pectoralis and serratus anterior group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • body mass index (BMI) from 20 - 35 kg/m2, ASA physical status I\&II

You may not qualify if:

  • Patients with signs of active infection or infection at the site of block placement.
  • Refusal of consent. History of any motor or sensory deficits as peripheral neuropathy, history of stroke with residual muscle weakness, multiple sclerosis, pre-existing sensory loss as diabetic neuropathy, spinal cord injury, spine abnormalities as kypholordosis.
  • Hypersensitivity or allergy to the drugs used for block. Patients with coagulopathy or on anticoagulant therapy. Extended incision not covered by the block (posterior or medial extended incision).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Minya university

Minya, Minya Governorate, 61511, Egypt

Location

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Saposins

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Sphingolipid Activator ProteinsCoenzymesEnzymes and Coenzymes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Aya Sedeek Mostafa

Study Record Dates

First Submitted

September 28, 2026

First Posted

October 2, 2026

Study Start

April 1, 2025

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

November 1, 2026

Last Updated

October 2, 2026

Record last verified: 2025-11

Locations